Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q3 2024 · 10-Q
Revenue$93.43M$93.43M+18.2% vs Q3 2023 Net Income-$220.52M-$220.52MN/M vs Q3 2023 EPS Diluted-$1.27-$1.27N/M vs Q3 2023 Operating Income-$213,429,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$184,605,000N/M Margins · derivedOperating margin-228.4%−41.7 pt vs Q3 2023
Net margin-236.0%−35.0 pt vs Q3 2023
ended Sep 30, 2024 · filed Oct 31, 2024 · 31 d after period end